INS and metabolic dysfunction-associated steatotic liver disease: (a) In vitro insulin-induced adipogenesis in 3T3-L1 preadipocytes and in vivo HFD-fed mice(b) Atherogenic diet-fed apolipoprotein E-deficient (ApoE-/-) mice(c) Patients with NAFLD associated with IR and diabetes